ReNeuron Group - Articles and news items

ReNeuron Group publishes stroke clinical data

Industry news / 4 August 2016 / Niamh Louise Marriott, Digital Content Producer

The PISCES I study was the first clinical trial of ReNeuron’s CTX cell therapy candidate for patients with motor disability as a consequence of ischaemic stroke. The data, collated over two years relates to the eleven stroke patients treated in the study…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+